Login / Signup

Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases.

Matthew KoslowMehrnaz Maleki-FischbachRebecca C Keith
Published in: Case reports in rheumatology (2021)
Interstitial lung disease (ILD) associated with connective tissue diseases (CTDs) is highly heterogeneous in its clinical presentation and course. The diagnosis and management of CTD-ILD require a multidisciplinary approach involving, at minimum, a rheumatologist, a pulmonologist, and a radiologist. Close monitoring of patients with CTD-ILD is important to enable early detection of disease progression and inform decisions regarding the initiation or escalation of pharmacotherapy. In the absence of guidelines regarding how CTD-ILDs should be treated, clinicians face difficult decisions on when to use immunosuppressant and anti-fibrotic therapies. The importance of a multidisciplinary and individualized approach to the diagnosis and management of CTD-ILD is highlighted in the three case studies that we describe in this article.
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • idiopathic pulmonary fibrosis
  • rheumatoid arthritis
  • clinical practice
  • palliative care
  • open label
  • clinical trial
  • smoking cessation
  • newly diagnosed
  • study protocol